Blueprint Medicines (BPMC) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Blueprint Medicines Corporation  (NASDAQ: BPMC)

Blueprint Medicines Corporation

Officers & Directors


Nicholas Lydon, Ph.D.
Director -

Michael Landsittel
Chief Financial Officer - (Principal Financial Officer)

Ariel Hurley
Senior Vice President, Finance -

Mark Goldberg, M.D.
Director -

Jeffrey W. Albers
Chairman of the Board of Directors -

Lynn Seely, M.D.
Director -

Alexis Borisy
Director -

Daniella Beckman
Director -

Habib Dable
Director -

John Tsai, M.D.
Director -

Kathryn Haviland
President, Chief Executive Officer and Director - (Principal Executive Officer)

Lonnel Coats
Director - ,

Blueprint Medicines Corporation currently has 582 employees.






BPMC Management Effectiveness BPMC Revenue per Employee BPMC Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.